Approved indications for Hyperbaric Oxygen Therapy in the Netherlands

12

Jul 2019

On the 11th of June 2019, the National Healthcare Institute (Zorginstituut Nederland, ZIN) has published a position regarding the positively assessed indications and the applicable protocols for Hyperbaric Oxygen Therapy (HBOT). Initially, the Dutch Society for Hyperbaric Medicine (NVvHG) has drawn up national protocols for some of the HBOT indications that have been included in the basic package since 2009 in order to promote the appropriate use of this care. Health insurers can include this information and the quality criteria of the protocols when purchasing HBOT.

Some of the considered indications are provided below:

  • Decompression sickness and arterial gas embolism
  • Intoxication by carbon monoxide (CO) in case of pregnancy or neurological, cardiac, pulmonary or psychic symptoms
  • Anaerobic or mixed soft tissue infections (excluding severe, life-threatening infections such as gas gangrene or necrotizing fasciitis)
  • Crush injuries, other acute traumatic ischemia with compromised circulation, compartment syndrome, replantation of extremities, skin and myocutaneous plastics with compromised circulation
  • Diabetic ulcers
  • Osteoradionecrosis (regardless of the localization area)
  • Radiation cystitis, proctitis, and enteritis
  • Treatment of chronic refractory osteomyelitis

See full details in Dutch here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more